MedTech lead generation: healthcare agencies compared for 2026
In short
MedTech lead generation runs on two motions, because the user is almost never the buyer. Clinical outreach builds an internal advocate. Administrative outreach reaches procurement, finance or a group purchasing organisation, where a conversation in March may only convert through a tender that opens in November. Health data is a GDPR special category, so outreach stays on public professional and institutional data. Four agencies are compared: Callbox, Belkins, MemoryBlue and Profitbl, plus our own entry.

On this page
Healthcare is the sector where generic outbound advice does the most damage. The buyer is rarely the person who uses the product, the procurement process is formalised in ways that most B2B categories never encounter, and the data protection stakes are higher than anywhere else, because health data is a special category under GDPR and mistakes there are not just embarrassing.
Agencies that run lead generation for healthcare and medtech in 2026:
- Callbox supports long procurement cycles with voice, nurturing and webinars, which matches how hospital and group purchasing decisions actually run.
- Belkins delivers multichannel appointment setting at scale with dedicated per-client teams across many verticals including healthcare.
- MemoryBlue supplies trained SDR teams for complex, high-value technology sales, which fits clinical software and devices.
- Profitbl brings senior SDRs and cold calling for health-tech companies expanding across Western Europe.
Healthcare procurement is long, committee-driven and phone-heavy, so a provider with voice capacity and nurturing infrastructure matches it better than an email-first agency. Our own entry sits last in the table and is labelled as ours.
How we compared them
- Procurement literacy. Can the agency handle formal tenders, framework agreements and group purchasing organisations rather than just booking a meeting?
- Buyer separation. Clinical users, administrative buyers and IT security are three different audiences with three different messages.
- Data protection posture. Health data is a special category under GDPR, and the outreach itself must stay well clear of it.
- Cycle patience. Twelve to twenty-four months is normal for anything touching clinical workflow.
- Channel reach. Hospital administrators and practice managers are reachable by phone and email; many are not active on LinkedIn.
The shortlist at a glance
| Agency | Voice capacity | Long-cycle support | Best healthcare fit | Pricing |
|---|---|---|---|---|
| Callbox | Substantial | Explicit, plus webinars | Hospital groups, long procurement | Custom |
| Belkins | Yes | Standard | Multi-country supplier programs | Custom |
| MemoryBlue | Yes | Standard | Clinical software and devices | Custom |
| Profitbl | Yes | Standard | Health-tech in Western Europe | Custom |
| Ripe Leads (our entry) | None | Restrained cadence | Suppliers and services to clinics and care operators | EUR 3750 first month, then EUR 2850/mo |
Four things that make healthcare different
The user is not the buyer, and often cannot buy
A ward nurse can tell you in thirty seconds whether your product solves a real problem. She almost certainly cannot authorise buying it. The person who can sits in procurement, finance or a group purchasing organisation, has never used the product, and evaluates it on price, contract terms, compliance and supplier stability.
This splits your outbound into two motions. Clinical outreach builds the internal advocate who says the problem is real. Administrative outreach reaches the person who can actually run a purchase. Sending the clinical message to procurement produces polite silence, and sending the procurement message to clinicians produces nothing at all.
Procurement is formal in a way most B2B is not
Public hospitals across Europe run tenders. Private groups run framework agreements and preferred-supplier lists. Both mean that a warm conversation in March may only convert through a process that opens in November, and if you are not on the framework you cannot sell at all regardless of how good the meeting was.
The practical consequence is that the most valuable outbound outcome in healthcare is frequently not a meeting. It is finding out when the framework is next reviewed and who owns it. An agency measured purely on booked meetings will systematically undervalue exactly the information you need.
Health data is a special category, and the outreach must stay away from it
GDPR treats data concerning health as a special category with a higher bar for processing. That does not stop you contacting a hospital administrator about a purchasing decision, because their name and work role are ordinary business contact data. It does mean the outreach must never touch patient information, must never imply you have access to clinical data, and must never use a clinical dataset as a targeting signal.
Ask any agency directly how they source healthcare contacts and confirm the answer is public professional and institutional information. In this sector a vague answer about data provenance is disqualifying rather than merely unhelpful.
Cycles outlast most agency contracts
Anything touching clinical workflow, patient records or accredited devices routinely takes twelve to twenty-four months from first contact to signature, with clinical validation, IT security review, data protection assessment and procurement approval along the way. A twelve-month agency contract can expire before your first deal lands, which tells you nothing about whether the programme worked.
Judge early quarters on the seniority and progression of conversations, not on revenue. Specifically: are you reaching people who sit on the buying committee, and are those conversations producing a named next step such as a security questionnaire, a pilot discussion or a framework date.
Who buys in healthcare: the audiences and what each one decides
MedTech outreach fails when one message goes to every audience. The table splits the buying committee as this page describes it.
| Audience | Role in the decision | What the outreach should do |
|---|---|---|
| Clinical user: nurse, clinician, ward manager | Confirms the problem is real, usually cannot authorise a purchase | Build an internal advocate with a message about the clinical problem |
| Procurement, finance or group purchasing organisation | Authorises the purchase on price, contract terms, compliance and supplier stability | Ask which framework applies and when it is next reviewed; send the administrative message |
| IT security and data protection | Reviews the product before purchase | Prepare for a security questionnaire and a data protection assessment |
| Practice manager, operations lead or owner at a clinic or care operator | Often runs the whole purchase for small sites | Reach by phone and email; many are not active on LinkedIn |
Cycles for anything touching clinical workflow, patient records or accredited devices run twelve to twenty-four months. Judge early quarters on named next steps: a security questionnaire, a pilot discussion or a framework date.
The agencies in detail
1. Callbox
Best for: Suppliers selling into hospital groups, care networks and public health organisations where procurement is formal and cycles are long.
Founded in 2004 and headquartered in Encino, California, Callbox brings more than 20 years of experience across North America, EMEA, APAC and LATAM. Services span ICP definition and prospect list building, appointment setting, data enrichment and account-based marketing, delivered across email, voice, LinkedIn and webinars, with explicit support for long sales cycles and substantial in-house data resources.
Three of those capabilities matter unusually much in healthcare. Voice reaches administrators and practice managers who do not live in an inbox. Nurturing keeps you present across a procurement cycle that may run for two years. Webinars are one of the few formats where clinical and administrative audiences will both spend time on a technical explanation.
Strengths:
- Genuine voice capacity, the strongest channel for administrative healthcare buyers
- Explicit long sales-cycle support rather than single-touch meeting booking
- Webinars, which suit regulated and technical explanations
- Account-based approach for pursuing named hospital groups and networks
- Multi-region delivery for suppliers selling across several health systems
Fit boundary: built for mid-market and enterprise scale. A small supplier selling to independent clinics in one country will find the model heavier and more expensive than the account values justify. Confirm native-language coverage per market, since health systems are national rather than pan-European.
2. Belkins
Best for: Healthcare suppliers with settled positioning that need multichannel outreach across several countries at once.
Founded in 2017, Belkins works with organisations across more than 50 industries including healthcare, delivering appointment setting, cold email campaigns, LinkedIn lead generation and cold calling as part of a tailored strategy. Dedicated teams are assembled per client including account managers and SDRs, with first outreach often launching within about 14 days.
Strengths:
- Three channels including calling, planned as one programme
- Dedicated per-client teams rather than pooled resource
- Healthcare among its stated verticals, with pattern experience to draw on
- Capacity to run several national health markets in parallel
Fit boundary: the model expects clients to arrive with clear ICP and messaging, which is a real constraint in a sector where the buying committee is often unclear at the outset. Agree explicitly how not-now replies and framework dates are captured, because a meeting-count view will discard them.
3. MemoryBlue
Best for: Clinical software, medical device and health-tech companies whose first conversation must survive a technical or regulatory question.
MemoryBlue has more than 20 years of experience helping B2B and high-tech companies scale outbound pipeline, blending dedicated SDR and BDR teams with strategy, data, sales training, demand generation and technology under its SMART framework, with delivery across North America, EMEA, LATAM and APAC and a partnership with Operatix.
The training-led model is the relevant differentiator here. In medtech the first call frequently produces a question about integration, accreditation or data handling, and a rep who cannot hold that conversation loses the account before a specialist ever gets involved.
Strengths:
- Academy-style training producing reps who can discuss complex regulated products
- Dedicated SDR and BDR teams with multichannel outreach
- Recruiting capability if you later want the function in-house
- Multi-region delivery for companies entering several health systems
Fit boundary: built for complex, high-value technology sales at scale. A supplier of consumables or services to independent clinics will find the structure and cost disproportionate to the deal sizes.
4. Profitbl
Best for: Health-tech and SaaS companies expanding into France, BENELUX, DACH or the UK.
Profitbl is a European sales outsourcing partner combining go-to-market strategy alignment with multichannel execution driven by senior SDRs who specialise in SaaS and technology sales, across LinkedIn, cold email and cold calling, aiming at BANT-qualified meetings with onboarding often completed within seven days.
Strengths:
- Senior SDRs rather than junior headcount handling regulated conversations
- Cold calling included, which reaches administrative buyers
- Explicit qualification framework, useful when committees are large
- Genuine depth in Western European markets
Fit boundary: the specialism is B2B SaaS and technology rather than healthcare specifically, so regulatory and procurement nuance will come from you. Coverage is Western Europe, and pricing is quoted rather than published.
Where we fit: Ripe Leads
We publish this page, so we are not in the ranking above. Here is what we do, for comparison.
Best for: Suppliers and service firms selling to clinics, dental groups, care homes, laboratories and healthcare operators across the Baltics, DACH and Poland, where the buyer is administrative rather than clinical.
Ripe Leads is a lean, founder-led outbound agency based in Vilnius. The honest healthcare use case is narrow and worth stating precisely: we work well when your buyer is a practice manager, operations lead, facility manager or owner, and less well when the sale turns on clinical validation and a two-year tender.
Campaigns run on ICP-matched lists built from public business and professional registers rather than bought data, separate sending domains with warm-up, copy written in the prospect's language across seven languages, and restrained follow-up. Interested replies go straight to the client's inbox. Pricing is published: EUR 3750 for the first month including setup, then EUR 2850 per month, cancel any month with 28 days' notice, tools included.
The data discipline is the part that transfers best to this sector. We build lists from public institutional information, never from anything clinical, and every message identifies the sender and states where the data came from.
Strengths:
- Native-language outreach to operators across the Baltics, DACH and Poland
- Lists built from public registers rather than purchased, with clear provenance
- Restrained cadence, which suits a conservative audience
- Flat published pricing with no minimum term, useful when cycles are unpredictable
- Not-now replies tracked with review dates, which is where framework timing surfaces
Fit boundary: we have no cold-calling team, and telephone is a strong healthcare channel. We do not run tender or framework processes, we have no clinical or regulatory expertise, and we cannot support a multi-seat programme across several health systems. If your sale depends on clinical validation, accreditation or public tendering, Callbox or MemoryBlue are the better answer and we will say so on the call.
Questions to ask before you sign
How will you source healthcare contacts?
The answer must be public professional and institutional information. Anything vague about provenance, and certainly anything touching clinical or patient data, is disqualifying in this sector rather than merely a concern.
How do you separate clinical and administrative outreach?
You want two messages and ideally two sequences. An agency proposing one message for both audiences has not understood who signs.
What happens with a framework or tender answer?
In healthcare, learning that the framework is reviewed next March and who owns it is often worth more than a meeting. Ask whether that is recorded with a review date and re-contacted, or whether it disappears from reporting as a non-result.
What does month six look like?
Conversations with named members of the buying committee and a documented next step, not signed contracts. An agency promising healthcare revenue inside two quarters has not sold into this sector.
Which health systems have you actually worked in?
Health systems are national. Experience with German statutory insurers transfers poorly to the Polish private clinic market or the UK NHS. Ask for countries and institution types, then judge the resemblance to your target.
Which should you choose?
If you sell into hospital groups, care networks or public health organisations where procurement is formal and cycles run for years, Callbox has the voice capacity and nurturing infrastructure the process demands.
If your positioning is settled and you need multichannel reach across several countries, Belkins can run it at scale.
If you sell clinical software or devices and the first conversation must survive a technical question, MemoryBlue's training-led model is the differentiator.
If you are a health-tech company entering Western Europe with calling in the mix, Profitbl is built for that motion.
If your buyer is a practice manager, operations lead or owner at a clinic, dental group, laboratory or care operator in the Baltics, DACH or Poland, our own entry above describes that fit, without calling or tender support.
More on this: B2B lead generation for facilities management companies, GDPR-compliant cold email in Europe, cold email versus cold calling, lead generation companies in Europe.
Frequently asked
What is medtech lead generation?
How do medical device companies generate leads?
Does GDPR stop you doing cold outreach in healthcare?
Who actually buys in healthcare?
How long are healthcare sales cycles?
Why is a booked meeting the wrong metric in healthcare?
Where does Ripe Leads fit in healthcare?
Which healthcare lead generation agency is best for medtech?
Selling to clinics, labs or care operators?
Book a short strategy call. We will tell you honestly whether your buyer is reachable the way we work, and if your sale turns on tenders or clinical validation we will point you elsewhere.
Book a strategy call Or get a free target list first